Glucarpidase Approval in Europe for Methotrexate Toxicity in View Glucarpidase Approval in Europe for Methotrexate Toxicity in View

Glucarpidase, already approved in the US, has been shown to reduce methotrexate concentrations by up to 99% within 15 minutes of administration.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news